Financial Snapshot

Revenue
$4.032M
TTM
Gross Margin
56.71%
TTM
Net Earnings
-$9.739M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
106.34%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
-$9.652M
Q3 2024
Cash
Q3 2024
P/E
-1.116
Nov 29, 2024 EST
Free Cash Flow
-$2.865M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021
Revenue $0.00 $0.00 $0.00
YoY Change

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021
Revenue $0.00 $0.00 $0.00
Cost Of Revenue
Gross Profit
Gross Profit Margin

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021
Selling, General & Admin $4.928M $4.279M $1.081M
YoY Change 15.16% 295.74%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $4.928M $4.279M $1.081M
YoY Change 15.16% 295.74%
Operating Profit -$4.928M -$4.279M
YoY Change 15.16%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021
Interest Expense $219.7K $23.10K $5.980K
YoY Change 851.1% 286.25%
% of Operating Profit
Other Income/Expense, Net $14.95K $384.1K -$30.63K
YoY Change -96.11% -1354.03%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021
Pretax Income -$3.605M -$2.288M -$1.106M
YoY Change 57.6% 106.85%
Income Tax $419.1K $486.6K $1.780K
% Of Pretax Income
Net Earnings -$4.025M -$2.774M -$1.108M
YoY Change 45.07% 150.45%
Net Earnings / Revenue
Basic Earnings Per Share -$0.78 -$0.60
Diluted Earnings Per Share -$0.78 -$0.60 -$37.49K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021
Cash & Short-Term Investments $2.000K $78.20K $421.6K
YoY Change -97.44% -81.45%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $94.00K $172.5K $740.2K
YoY Change -45.51% -76.7%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $96.00K $250.7K $1.162M
YoY Change -61.71% -78.42%
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $23.30M $41.69M $232.3M
YoY Change -44.11% -82.05%
Other Assets $0.00 $165.2K
YoY Change -100.0%
Total Long-Term Assets $23.30M $41.69M $232.5M
YoY Change -44.11% -82.06%
Total Assets $23.40M $41.95M $233.6M
YoY Change
Accounts Payable $768.0K $195.1K $28.10K
YoY Change 293.73% 594.16%
Accrued Expenses $4.394M $2.260M $530.9K
YoY Change 94.39% 325.76%
Deferred Revenue
YoY Change
Short-Term Debt $4.682M $1.643M $72.86K
YoY Change 184.98% 2154.91%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $12.68M $4.186M $633.6K
YoY Change 202.96% 560.69%
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $8.000K $9.232M $9.613M
YoY Change -99.91% -3.97%
Total Long-Term Liabilities $8.000K $9.232M $9.613M
YoY Change -99.91% -3.97%
Total Liabilities $12.69M $13.42M $10.25M
YoY Change -5.43% 30.95%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021
Basic Shares Outstanding 6.540M 6.540M
Diluted Shares Outstanding 6.540M 6.540M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $10.869 Million

About QT IMAGING HOLDINGS, INC.

QT Imaging Holdings, Inc. is a medical device company, which engages in the research, development, and commercialization of body imaging systems using low energy sound. The company is headquartered in Novato, California. The company went IPO on 2021-09-24. Its medical imaging is critical to the detection, diagnosis, and treatment of disease. The firm offers two products: QT Breast Scanner and QTviewer. QT Breast Scanner is a fixed, mechanical scanner used to evaluate the breast without the use of either ionizing radiation or compression associated with mammography, or the injections required for breast MRI. The QT Breast Scanner provides sub-millimeter, high-definition, image resolution enabling identification of normal and abnormal breast structures and the accurate depiction of the precise shape and location of findings. The QT Breast Scanner creates 3D images of the patient’s breast viewable in the Quantitative Transmission Ultrasound Viewer (QTviewer), a software product designed for healthcare professionals to view the transmission and reflection images.

Industry: Electromedical & Electrotherapeutic Apparatus Peers: ABBOTT LABORATORIES RemSleep Holdings Inc. Stimcell Energetics Inc. STRATA Skin Sciences, Inc. PetVivo Holdings, Inc. SCIENTIFIC INDUSTRIES INC VAPOTHERM INC